The global epidemiology of hepatocellular carcinoma: present and future
about
Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinomaRelative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic ReviewHepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Potential role of High mobility group box 1 in hepatocellular carcinomaRole of endoscopic ultrasound in diagnosis and management of hepatocellular carcinomaNoncoding RNA Profiles in Tobacco- and Alcohol-Associated DiseasesNCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinomaGlobal geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwideHIV, Aging, and Viral Coinfections: Taking the Long View.Accuracy of computer-aided ultrasound as compared with magnetic resonance imaging in the evaluation of nonalcoholic fatty liver disease in obese and eutrophic adolescents.Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study.Hepatocellular carcinoma and antidepressants: a nationwide population-based study.NCOA5, a molecular link between type 2 diabetes and liver cancer.Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.Extraordinary radiation super-sensitivity accompanying with sorafenib combination therapy: what lies beneath?Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study.1, 25(OH)āDā inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytesRisk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control studyMutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-GuaChanging hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.Cause-specific telomere factors deregulation in hepatocellular carcinoma.Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review.Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling ProjectIdentification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary CareGenetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.
P2860
Q24202070-0390B56A-48FC-4EFC-94FB-06D671F17DC3Q26745892-40B1E691-8868-43FC-9724-E8F702192EA1Q26767217-890C1E5E-F5B3-4EAA-A591-51AB7E1ADB1CQ26824893-DC733CC9-1064-4C6A-8D2E-E71BF0E9A8D7Q26864508-324FA51A-BB3D-4861-B705-94FF93B26B3CQ27336354-E55970C7-61A6-40A3-B52A-02784405CFAAQ28079874-1F970293-AC55-427F-9193-10195A8FFE2EQ28586911-0A8565EE-A1A8-4FC5-8FBE-BEE3809BADA6Q28706340-5E67F033-E0E3-47AD-8BF1-7D3543D7346DQ30245486-7229868E-6DEA-44CC-A2E6-81B79143C3F5Q30403032-57BE1D30-53FB-442B-A2A0-4B660EC414E8Q30584496-576B3F42-EC28-4637-B245-3013BB3E4570Q30746254-EC2336F8-49FE-48FC-9A76-3CB48C37B02FQ33566885-CC254AAB-0FB2-4EE7-85AF-A5FA4ECBFB78Q33630432-77A7C307-D255-46D9-BFB9-28A20B002B7CQ33722491-9D102524-2C46-4F2B-A2F2-0D37DA568C00Q33728349-B764C605-0924-48B3-AB8F-8267CAA9F6CFQ33814414-24487484-2937-454B-B108-31EAE4AE9F67Q33910326-6A690ED7-19B7-46AA-BD9A-6F82203526D4Q33919709-0105B3BA-02D7-4470-8187-CFE35B5D85BBQ33946524-B1F0168D-78B5-418C-8FE4-7318B1536ABAQ33956888-279FB7C3-C13C-41DE-9B9C-41F8F8288F83Q33958789-B505CD8D-0A45-4C68-8DBF-519B201BBEDFQ33968053-5B49A1FA-4BC1-4EF7-AFA4-F48C1C145989Q34073971-518B2BF8-B22B-44BD-A6DC-17128F232C66Q34107531-50B115DA-D40C-4445-9D0E-E49502A22527Q34243903-A07B3982-A03C-414C-95DE-88EF1DE59577Q34408236-ADDABC79-675E-434E-800D-A1BEE859C89AQ34681076-D381BE27-573B-486B-AA13-9CA7566D345EQ34982993-68E2B251-1CD4-4511-B05F-70582AB4D1DCQ35094632-24D39219-B6BC-49BE-9D20-17939380F3CAQ35108552-C4119D09-6B33-462F-88DA-7B7C43D0FB17Q35152907-1FBC4413-1667-4FAC-913D-E6219236961AQ35158760-BF08AA0F-C4A5-4CC7-8BBA-768A6EEF405AQ35169398-6C835C7B-8A2D-44A9-BC9C-10C3213B9ACFQ35274912-561CF627-5970-41CD-876B-3E3FC26D2108Q35611332-E948B3C1-FA19-4EBC-BE2E-D4712487B0FDQ35678036-EE9F674A-1FDC-4B00-971B-02737BFA2194Q36015496-A9AD74EC-1003-48F2-9686-A60D95558AD9Q36025479-9F72C853-8F4F-4FCE-9DC6-12E60088B797
P2860
The global epidemiology of hepatocellular carcinoma: present and future
description
2011 nĆ® lÅ«n-bĆ»n
@nan
2011 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ”ÕµÕ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2011 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ“Õ”ÕµÕ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2011幓ć®č«ę
@ja
2011幓č«ę
@yue
2011幓č«ę
@zh-hant
2011幓č«ę
@zh-hk
2011幓č«ę
@zh-mo
2011幓č«ę
@zh-tw
2011幓č®ŗę
@wuu
name
The global epidemiology of hepatocellular carcinoma: present and future
@ast
The global epidemiology of hepatocellular carcinoma: present and future
@en
The global epidemiology of hepatocellular carcinoma: present and future
@nl
type
label
The global epidemiology of hepatocellular carcinoma: present and future
@ast
The global epidemiology of hepatocellular carcinoma: present and future
@en
The global epidemiology of hepatocellular carcinoma: present and future
@nl
prefLabel
The global epidemiology of hepatocellular carcinoma: present and future
@ast
The global epidemiology of hepatocellular carcinoma: present and future
@en
The global epidemiology of hepatocellular carcinoma: present and future
@nl
P2860
P3181
P1476
The global epidemiology of hepatocellular carcinoma: present and future
@en
P2093
Katherine A McGlynn
W Thomas London
P2860
P304
223-43, vii-x
P3181
P356
10.1016/J.CLD.2011.03.006
P407
P577
2011-05-01T00:00:00Z